Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV‐2287: an animal model with implications for maternal–neonatal HIV transmission

A model of vertical HIV transmission was developed using oral HIV‐2287 exposure of newborn Macaca nemestrina. The minimal Animal Infectious Dose for this oral route was found to be 10‐fold higher than that for atraumatic viral transmission across other mucosal membranes (vaginal/rectal) of juvenile macaques. However, once infection was established, viral replication was rapid and plasma viremia could be detected by reverse‐transcriptase polymerase chain reaction and viral co‐culture within 1 week following exposure. No animal was resistant to infection and all macaques initially exposed to a subinfectious viral inoculum were subsequently infected by re‐exposure of mucosal membranes. Higher viral load during primary infection correlated with a more rapid CD4 depletion; however, all HIV‐2287‐infected animals developed CD4 depletion during the observation period. This animal model can now be used to study early viral replication in the presence and absence of anti‐retroviral agents to help identify conditions to reduce vertical HIV transmission in human newborns.

[1]  Tahir A. Rizvi,et al.  Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection , 2000, Nature Medicine.

[2]  Dorothy Bray,et al.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.

[3]  R. Steinman,et al.  Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. , 1999, Science.

[4]  M. McElrath,et al.  Dendritic Cell–T-Cell Interactions Support Coreceptor-Independent Human Immunodeficiency Virus Type 1 Transmission in the Human Genital Tract , 1999, Journal of Virology.

[5]  S. Kwok,et al.  Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. , 1998, The Journal of infectious diseases.

[6]  B. Sha,et al.  Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. , 1998, MMWR. Morbidity and mortality weekly report.

[7]  M. Newell,et al.  Maternal viral load, CD4 cell count and vertical transmission of HIV‐1 , 1998, Journal of medical virology.

[8]  M. Nowak,et al.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection , 1997, Journal of virology.

[9]  N. Haigwood,et al.  Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. , 1997, AIDS research and human retroviruses.

[10]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[11]  L. Mofenson.  Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[12]  C. Rouzioux,et al.  Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group. , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[13]  L. Foresman,et al.  Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS , 1997, Journal of virology.

[14]  N. Haigwood,et al.  Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival , 1997, Journal of virology.

[15]  R. Desrosiers,et al.  Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus , 1997, Nature Medicine.

[16]  M. Murphey-Corb,et al.  Infection and AIDS in Adult Macaques After Nontraumatic Oral Exposure to Cell-Free SIV , 1996, Science.

[17]  J. Clements,et al.  Genotypic analysis of infant macaques infected transplacentally and orally , 1996, Journal of medical primatology.

[18]  B. Masquelier,et al.  Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. , 1996, JAMA.

[19]  A I Spira,et al.  Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques , 1996, The Journal of experimental medicine.

[20]  D. Dimitrov,et al.  Kinetics of HIV-1 RNA concentration changes in pediatric patients. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.

[21]  L. Montagnier,et al.  Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. , 1995, Virology.

[22]  N. Pedersen,et al.  Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques , 1995, Journal of virology.

[23]  R. Bronson,et al.  Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. , 1995, Science.

[24]  M. Murphey-Corb,et al.  Neonatal disease induced by SIV infection of the rhesus monkey (Macaca mulatta). , 1993, AIDS research and human retroviruses.

[25]  R. Henrion,et al.  HIV replication during the first weeks of life , 1992, The Lancet.

[26]  L. Corey,et al.  Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. , 1992, The Journal of infectious diseases.

[27]  E. Clark,et al.  Development of lymphocyte subsets in pigtailed macaques. , 1988, Human immunology.

[28]  C. Wilson,et al.  Immunologic basis for increased susceptibility of the neonate to infection. , 1986, The Journal of pediatrics.